Key Slides

Resistance in Long-Acting Therapy for Prevention and Treatment: Uncommon Outcome or Achilles HeelPresenter: Joseph J. Eron, Jr, MD Click to Download Slides On-Demand Webcast Podcast iasusa · Resistance in Long-Acting Therapy for Prevention and Treatment: Uncommon Outcome or Achilles Heel Text on the button

Annoying But Necessary: Navigating the Operational Challenges of Long-Acting Treatment and Prevention StrategiesPresenter: Joshua P. Havens, PharmD Click to Download Slides On-Demand Webcast Podcast iasusa · Annoying But Necessary: Navigating the Challenges of LA Treatment & Prevention Strategies Text on the button

Challenging Cases in Long-Acting Treatment and Prevention: What Would You Do?Presenter: Raphael J. Landovitz, MD, MSc Click to Download Slides On-Demand Webcast Podcast iasusa · Challenging Cases in LA Treatment and Prevention: What Would You Do? Text on the button

State of the Science: What We Know about Long-Acting Injectable Agents for Treatment of HIVPresenter: Aadia I. Rana, MD Click to Download Slides On-Demand Webcast Podcast iasusa · State of the Science: What We Know about Long-Acting Injectable Agents for Treatment of HIV Text on the button

State of the Science: What We Know about Long-Acting Injectable Agents for HIV PreventionPresenter: Colleen Kelley, MP, MPH Click to Download Slides On-Demand Webcast Podcast iasusa · State of the Science: What We Know about Long-Acting Injectable Agents for HIV Prevention Text on the button

Recipient: Gerald H. Friedland, MD

Co-Chairs: Elaine J. Abrams, MD, and Raphael J. Landovitz, MD

Co-Chairs: Elaine J. Abrams, MD, and Raphael J. Landovitz, MD

Presenter: Ole-Petter R. Hamnvik, MB BCh BAO, MMSc